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Background: Diabetes prevalence has become a global crisis. Due to the substantial rise in smartphone use, a
variety of mobile interventions have been developed to help improve the clinical outcomes of diabetes patients.
Objectives: This study seeks to examine specific behavior change theories and techniques used in the design of
self-management mobile app-based interventions aimed at achieving glycemic control in type 1 and type 2
diabetes.
Methods: A meta-analysis of randomized control trials published in PubMed/Medline and Web of Science be
tween January 2010 and October 2020 was conducted using studies that included diabetes patients, reported on
well-described mobile app-based interventions, compared mHealth to usual care, and evaluated glycated he
moglobin (HbA1c) at baseline and follow-up.
Results: We reported on 21 studies with a total of 1,920 diabetes patients. Our findings show that mHealth apps
led to statistically significant clinical outcomes as compared to standard care for glycemic control (− 0.38, 95%
CI = − 0.50 to − 0.25, p < 0.0001) indicating that such interventions result in a reduction in HbA1c. Interventions
that used behavior theory for developing mHealth apps were not statistically different from those that did not (p
= 0.18). However, increased use of behavior change techniques (BCTs) may result in slightly higher HbA1c
reduction. Among all BCTs, the most effective ones appear to be “Action planning” and “Self-monitoring of
outcome(s) of behavior.
Conclusions: The current meta-analysis provides evidence that mHealth is likely to be beneficial for diabetes
patients when the right behavior change techniques are applied to realize the full advantage of the intervention.
Further investigation of the role of theory in the design of mHealth app-based interventions is warranted.

1. Introduction
The rapid increase in the number of people living with diabetes is a
global crisis that places a huge burden on public health systems. For
example in the United States alone, 34.1 million adults (aged 18 years
and above) – which represents 13% of population estimates – have
diabetes [1]. An additional 88 million adults have prediabetes, a con
dition that can lead to type 2 diabetes within five years if left untreated.
Further, Saeedi et al. [2] placed global estimates at 9.3% (463 million
people), which is expected to rise to 10% (578 million people) and
10.9% (700 million people) by 2030 and 2045, respectively. The
increasing number of diabetes patients, especially those with type 2
diabetes, has been attributed to obesity, aging, and increased urbani
zation. This issue is reflected in the elevated prevalence rates in urban

areas (10.8%) and high-income countries (10.4%) relative to rural areas
(7.2%) and low-income countries (4.0%) [2].
Given these worrying trends, the development of diabetes solutions
has remained at the forefront of medical and technological innovation
especially regarding mobile health (mHealth) which supports the selfmanagement of the condition. In fact, out of the approximately
325,000 mHealth applications on the Apple App and Google Play stores,
diabetes is the second most popular use case after “connection to doctors”
[3]. Studies show that mHealth interventions result in improvements in
various clinical outcomes in diabetes patients. Past reviews [4–6] indi
cate, based on a qualitative synthesis of clinical trials, that mHealth
interventions are effective for diabetes management. Additionally,
various meta-analyses [7–12] corroborate the efficacy of mHealth in
terventions for improving clinical outcomes based on quantitative
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evidence. Yet, those studies did not focus on the role of behavior change
or the underlying theoretical basis.
Since diabetes management is primarily a behavioral issue that re
quires extensive self-management [13], the role of specific behavior
change techniques (BCTs) for improving health outcomes cannot be
understated. BCTs are observable, replicable, and irreducible compo
nents of the interventions that lead to causal processes meant to regulate
behavior [14]. Further, there are assertions that the use of theory leads
to more effective intervention [15–21]. However, there is concern over
the importance of theory [22], and little remains known of the specific
BCTs that encourage health behavior change in diabetes patients leading
to the clinical improvements reported. Out of the studies mentioned,
only one qualitative review [6] identified the BCTs frequently used in
effective interventions. While past studies quantified the effect of BCTs
in Internet-based interventions [21], dietary interventions [23], and
physical activity interventions [24], there has been no meta-analysis
investigating the effect size of mobile-based interventions for diabetes
self-management with a particular focus on exploring the role of
behavioral change techniques and theory.
This study aims to systematically review and evaluate the quantita
tive effect of BCTs in mobile app-based self-management interventions
for achieving glycemic control in diabetes patients as reflected by HbA1c
values. Further, this study investigates which specific behavioral change
theories and techniques are incorporated in the design of diabetes mo
bile app-based interventions, and their role in enacting behavioral
change and ultimately glycemic control. Specifically, we aim to address
the following questions: What is the efficacy of theory-based mobile appbased interventions for diabetes self-management? Which theories are
associated with improved outcomes, and which behavior change tech
niques are effective when delivered via a mobile app employed over the
Internet?

Medline, and the equivalent topic search applied in Web of Science. In
order not to inadvertently rule out any potentially useful study, we
carefully examined citations of prior related reviews [4–12].
2.2. Inclusion and exclusion criteria
With the research objectives in mind, studies were included if 1) the
study participants were adults (older than 18 years) who had been
diagnosed with type 1 diabetes (T1D) or type 2 diabetes (T2D). With a
focus on behavioral changes, the nature and context for individuals
under 18 can be substantially different than those 18 years or older.
Further, there are unique challenges in managing diabetes through
hormonal and physiological turbulence of puberty and adolescence
[26]; 2) the primary intervention was a mobile application where a
mobile application in the context of this review is a computer program
that is designed to run on a mobile device such as a phone or another
mobile device such as a tablet or a watch [27,28]; 3) the intervention
was well described to allow coding of behavior change technique(s); 4) a
randomized control trial (RCT) was used in the study design; 5) the RCT
consisted of at least a control arm and one intervention. The control
referred to ‘standard/usual/traditional’ whereas the intervention
included such care in addition to the mobile application-based inter
vention, 6) outcomes included glycemic control as measured by a
change in glycated hemoglobin (HbA1c) at baseline and follow-up, and
7) the intervention effects were reported in a manner that allows for the
computation of effect size. When the study data was missing the stan
dard deviation (SD) but reported the standard error (SE), the SD was
computed per the Cochran guidelines [29]. If both the SD and SE were
missing, the authors were emailed for study data. Studies were also
included if either the evaluation or the intervention arm of the study was
published in a separate paper not captured in our initial search. Only
peer-reviewed studies published in the English language were consid
ered for this meta-analysis. Nonrandomized studies, not controlled,
quasi-experimental, and partial results were excluded. Studies involving
mobile applications that primarily focused on mobile phones for con
nectivity, e.g., by transmitting short message service (SMS) or by the
Internet for remote monitoring were excluded. For example, using a
phone for solely sending blood glucose measurements via SMS or other
means is outside the scope of this review. Studies that were aimed at
health professionals were also excluded.

2. Methods
The current study follows the Preferred Reporting Items for Sys
tematic Reviews and Meta-Analyses (PRISMA) guidelines for conducting
systematic reviews [25]. PRISMA offers a standardized and replicable
approach to identifying, selecting, and critically appraising extant
literature.
2.1. Data sources and search strategy

2.3. Data extraction

We searched PubMed/Medline and Web of Science databases for
relevant English-language peer-reviewed articles, conferences, and book
chapters published between January 2010 and October 2020. This study
period was appropriate to deliver an up-to-date review of current mobile
app-based interventions for diabetes self-management. This is particu
larly important given the rapid change in technology and supporting
infrastructure. The search terms targeted the root term diabetes com
bined with various combinations of mobile technologies, mHealth, and
behavior change. The wildcard character (*) was used to target variations
on the term “behavior” in the literature such as behavioral, behaviors,
and others. Table 1 demonstrates the search query used in PubMed/

All identified studies were exported to the Zotero reference manager
software [30]. After removing duplicates, two researchers indepen
dently read the title and abstracts of all studies and marked them for
inclusion or exclusion. The full text of each of the remaining articles was
then added to the reference manager for full-text synthesis. For studies
that passed full-text screening, data included authors, year and country
of publication, patient sample sizes, study design, diabetes type, inter
vention and control description, key outcome measure, and longest
follow-up periods. If a study reported more than one intervention group,
we included all interventions that encompassed variations in the extent
of the supported behavioral change techniques. When the same partic
ipants were part of separate studies (duplicate publications), we re
ported on only one study. The primary outcome of interest was HbA1c as
it is the gold standard to monitor glycemic control and hence the
effectiveness of diabetes management [31,32]. HbA1c reflected the ul
timate health outcome of an intervention, regardless of whether the
behavioral change was considered as a mediator and whether it was
explicitly measured across studies.

Table 1
Search query.
Database

Search Query

PubMed/
Medline

(diabetes) AND
(((smartphone OR mobile OR android OR iphone) AND
(app OR application)) OR (mhealth)) AND
((behavior* OR lifestyle) AND (change OR modification))
TS=(diabetes) AND
((TS=(smartphone OR mobile OR android OR iphone) AND
TS=(app OR application)) OR TS=(mhealth))AND
(TS=(behavior* OR lifestyle) AND TS=(change OR
modification))

Web of Science

2.4. Coding of behavior change techniques
The current study employed the list of 93 hierarchically clustered
BCTs taxonomy (v1) developed by Michie et al. [14] to code the
2
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presence or absence of each technique. Both intervention and control
conditions were coded separately and independently by two researchers
using all available primary papers, related papers, and protocols for a
comprehensive assessment of each included study. BCTs taxonomy (v1)
application [33], the BCT training material (http://www.bct-taxonomy.
com), and the original study [14] were used to aid with the coding of
BCTs. Following the example of past studies [21], a BCT was coded as
absent if it was present in both the experimental intervention and the
control since it could not sufficiently explain the difference between the
two groups. Inter-rater reliability for the entire process was calculated
using Cohen’s kappa to measure the rate of agreement between the two
coders. Any discrepancy in the coding was resolved by revisiting the BCT
guidelines and the supporting coding examples.

differences in the regression model. In each case, the analysis was only
conducted for variables present in more than two interventions to ensure
reliability.
3. Results
3.1. Literature screening
As shown in Fig. 1, 21 studies were identified for inclusion in this
meta-analytic review. These studies were identified from a total of 629
records obtained from a search in PubMed/Medline (404) and the Web
of Science (225) databases. The search for citations of recent related
reviews yielded 15 additional studies [4–12]. After combining all studies
and removing duplicates, 488 records remained. Based on the inclusion
and exclusion criteria, 85 records remained after screening the title and
abstract and 21 studies remained after screening the full-text. Three
studies [46–48] included more than two arms, hence we reported on 21
studies and 24 interventions.

2.5. Assessment of bias and overall quality of evidence
Using Cochrane Collaboration’s risk of bias tool, two authors inde
pendently assessed all studies for risk bias in 1) random sequence gen
eration; 2) allocation concealment; 3) participant and personnel
blinding; 4) outcome assessment blinding; 5) incomplete outcome data;
and 6) selective reporting. A categorical ranking of low (green), unclear
(yellow), and high (red) was assigned at each step. As suggested in the
Cochrane Handbook [29], both reviewers resolved any disagreements
via discussion and resorted to the third author to adjudicate the final
judgement as needed. Publication bias was evaluated using Egger’s test
and visualized on a funnel plot [34].
Further, two reviewers assessed the evidence independently using
the Grading Recommendations Assessment, Development and Evalua
tion (GRADE) tool [35] for the outcome under consideration. According
to GRADE, the focus is on the body of evidence as opposed to an indi
vidual study. There are four categories: high, moderate, low, and very
low. RCTs start with a ‘High’ rating. The quality is downgraded in light
of five factors (Risk of Bias, Inconsistency, Indirectness, Imprecision,
Publication Bias) and rated up for three factors (Large effect, Doseresponse, All plausible residual confounding) [36]. We follow the rec
ommendations in [37] in communicating the findings.

3.2. Study and participant characteristics
The characteristics of the 21 selected studies are presented in
Table 2. The studies included RCTs conducted in 19 countries including
the United States (3) [49–51]; China (3) [48,52,53]; Netherland (2)
[54,55]; Norway (2) [47,56]; Australia [57]; China and Taiwan [58];
Canada [59]; Finland [60]; France [46]; India [61]; Indonesia [62]; Italy
[63]; Japan [64]; Sri Lanka [65] and the United Kingdom [66].
A total of 1,920 patients were involved in the studies with 1,040 of
them participating in the mHealth interventions and 880 in the control
group. The patients had a mean age of 51.2 years (32.9–68.1 years) and
study durations ranged from 3 months to 18 months. Five studies
designed interventions specifically for T1D [46,55–57,63] while two
other studies involving applications aimed at both T1D and T2D
[48,66]. All remaining interventions were designed for T2D. Initial
coding of BCTs resulted in an inter-rater reliability Cohen’s kappa of
0.67 indicating substantial agreement between the two coders. Any
discrepancy in the coding was resolved by revisiting the BCT guidelines
and the supporting coding examples.

2.6. Data analysis and synthesis
Data analysis was conducted using the metafor package for con
ducting meta-analysis in R [38,39]. Review Manager Version 5.4 for
Windows [40] was used to record the risk of bias assessment. Results
were presented as mean difference (MD) using the follow-up score and
SD for HbA1c with a 95% confidence interval (CI). Since mixing out
comes does not affect analysis [29], the change score was used whenever
the follow-up score was not available.
Following the precedent set by earlier research [23,41,42], we
defined the effectiveness of interventions based on glycemic control as
≥0.3% reduction in HbA1c. Further, effect sizes were interpreted in the
context of prior related meta-analyses and Cohen’s guidelines [43].
According to Cohen [44], d = 0.20 is considered a “small” effect size, d
= 0.50 is a “medium” effect size, whereas d = 0.80 is a “large” effect size.
In all cases, the random-effects model was used. The random-effects
model is appropriate when there is an expectation of complex
differing study characteristics [45]. Study heterogeneity was evaluated
using Higgins I2. The results of heterogeneity were considered low at
25% and moderate between 50% and 75%.
We conducted moderator analyses to evaluate the role of theory and
behavioral change techniques as well as the other moderators of effect
size, e.g., the type of diabetes and the length of the intervention. For
categorical variables, such as the presence of theory or a particular
behavior change technique, we conducted a subgroup analysis. For
continuous variables, such as the number of BCTs used or the duration of
the intervention in months, we used a meta-regression. Where a metaregression was performed, the estimate (ß) and p-value were used to
interpret whether the predictor could significantly predict the effect size

3.3. Assessment of bias and overall quality of evidence
Most studies (81%) exhibited a low sequence generation Risk of Bias
(RoB) while a lower percentage (57%) exhibited a low allocation
concealment RoB. No study was identified as having a high risk of se
lection bias, while three studies exhibited an unclear risk of sequence
generation and allocation concealment selection bias. However, and due
to their nature, blinding of participants and personnel was not possible
in any of the studies resulting in a high RoB. All studies relied on an
objective measure (HbA1c) and thus were judged as being at low RoB for
blinding of outcome assessment. All studies exhibited a low risk of
attrition bias. Further, the final publication of the trial followed what
had been planned in a published protocol paper, or in the case where no
protocol paper was publicly available, the studies reported all the out
comes, namely, HbA1c, mentioned in the methodology and thus were
judged as having a low risk for selective outcome reporting. Fig. 2 shows
the risk of bias graph and summary for the selected studies.
Egger’s test for publication bias did not indicate the presence of
publication bias (p = 0.41). This was confirmed visually by a funnel plot
(Fig. 3).
Based on the GRADE quality of evidence assessment approach, the
quality of evidence was rated as high with respect to the collective body
of evidence regarding the use of mobile apps for diabetes selfmanagement. However, when considering the use of theory and sup
port for BCTs, the quality ranged from moderate to very low. The
moderate rating was attributed primarily to the indirectness related to
the intervention, i.e., that the intervention as defined by the presence of
3
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Fig. 1. PRISMA flow chart of the study selection process.

theory or specific BCT may differ from the intervention of interest as
their interpretation and coding were dependent on the details provided
in the literature reporting said interventions. This is a shortcoming that
has been reported in reviews of this nature [6,21,23,24]. Further, in the
moderator analysis, the evidence may be downgraded to low or very low
mostly due to the low number of studies that may be present in a
particular group resulting in imprecision, or in sub-groups exhibiting a
high level of heterogeneity resulting in inconsistency. Below we present
the results in accordance with the recommendations in [37] for
communicating the findings.

3.5.1. Use of behavior theory
A summary of the effect of behavior theory and techniques is out
lined in Table 3. A total of 8 interventions referenced a theoretical basis
for their design, while the remaining 16 interventions did not include
any reference to theory. Both groups resulted in a significant reduction
in HbA1c with effect sizes of (− 0.36, 95% CI − 0.60 to − 0.13, p = 0.002)
and (− 0.39, 95% CI = − 0.54 to − 0.24, p < 0.0001) for studies with
theoretical basis and those without theoretical basis, respectively.
However, there was no significant difference (p = 0.86) between the two
groups.
Studies that referred to a theory base often cited more than one
theory. The highest number of theories used for any one intervention
was four [54,61,66]. Two other studies utilized multiple theories
[49,58] while the remaining interventions were based on a single
behavior theory [50,60,62]. The two most prominent theories that were
used in the studies were the Transtheoretical Model of Behavior Change
(TTM) and the Social Cognitive Theory (SCT). TTM, which theorizes
change as a progressive venture through pre-contemplating of behavior
change to behavior maintenance [67], was applied in three studies
[49,54,58]. SCT, which emphasizes knowledge acquisition through so
cial contexts and includes self-efficacy as one of the four processes of
goal realization, was applied in [49,61,62,66]. For both theories, the
effect size was not significant as shown in Table 3. However, the quality
of evidence exhibited indirectness (as noted earlier), and imprecision
rendering it of low certainty. For TTM, inconsistency associated with
heterogeneity (I2 = 56%) was deemed of questionable importance as the
difference was between large and small effects. Accordingly, in
terventions based on the TTM or the SCT may reduce HbA1c slightly.
Further, comparing the studies that used any of these two theories
against those that did not, revealed no statistically significant

3.4. Overall effect of mHealth interventions on glycemic control
As demonstrated in Fig. 4, the pooled estimate of study data
demonstrated a statistically significant improvement in HbA1c levels of
mHealth intervention participants as compared to standard care treat
ment (− 0.38, 95% CI = − 0.50 to − 0.26, p < 0.0001). Heterogeneity was
low at I2 = 0% which indicated that variability across the trials was not
an issue. Overall, mobile app-based interventions resulted in a reduction
in HbA1c.
3.5. Moderator analyses
Moderator analyses were conducted to investigate the impact of the
different participants, study, and intervention characteristics on the
pooled effect size. We evaluated the presence of theory and various BCTs
as well as the type of diabetes and intervention duration in mHealth
intervention design with respect to improving glycemic control.

4
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Table 2
Study characteristics.
Intervention Description

Diabetes
Type
Targeted

Longest
Follow-up
(months)

(Baron et al.,
2017) [66]
United Kingdom

Mobile Telehealth (MTH) consisting of mobile
and application, BG meter, BP monitor, and
Bluetooth cradle to store and transmit diabetesrelated data. Includes data visualization of
recorded data and highlighting out-of-range
readings.

T1D; T2D

9

(Bender et al.,
2017) [49]
United States

PilAm Go4Health intervention consisting of a
Fitbit accelerometer, a mobile app with a diary
for health behavior tracking. Provided social
support and education through social media

T2D

(Boels et al., 2019)
[54]
Netherlands

TRIGGER study consisting of a smartphone app
to provide diabetes self-management education
and support using text messages and prompts

T2D

(Chao et al., 2019)
[58]
Taiwan and
China

Interactive Personalized Management
Framework (IPMF) application cloud-based for
smartphones to consolidate patient-related
information to a dashboard. Included personal
goal setting and diabetes education

T2D

(Charpentier
et al., 2011)
[46]
France
(Drion et al.,
2015) [55]
Netherlands
(Gunawardena
et al., 2019)
[65]
Sri Lanka
(Holmen et al.,
2014) [47]
Norway
(Hsu et al., 2016)
[50]
United States

Diabeo software to support bolus calculation.
Data recorded included self-monitoring plasma
glucose, diet, and insulin treatment. One group
received teleconsultation assistance.
Dbees application to support customized
treatment plans, prompts and reminders, and
visualize collated data
Smart Glucose Manager (SGM) to remind and
support medication and physical activity.
Provided bolus insulin calculation.

T1D

6

Theory(s) Used: Transtheoretical Model
of Behavior Change, Theory of Planned
Behavior
N/A

T1D

3

T2D

FTA app to aid the collection of glucose and
dietary data and visualization. Includes support
for physical activity and tailored feedback
CollaboRhythm application for self-tracking of
blood glucose and data visualization. Provides
insulin titration support, carbohydrate counting,
and telehealth consultations
Glucose Buddy includes manual entry of
diabetes-related data and physical activity.
Supports goal setting and graphical display of
data
Gather mHealth platform consists of an
application and a web portal for providers. App
has reminders, data visualization, and support
for collaborative care decisions.

T1D

9

T2D

6

(Kusnanto et al.,
2019) [62]
Indonesia

DM-calendar app designed to support selfmanagement with four main components; blood
sugar control, education program, nutrition
therapy, and physical activity.

T2D

(Orsama et al.,
2013) [60]
Finland

Monica app and Medinet web interface for
collecting diabetes-related data and receiving
tailored feedback

T2D

(Quinn et al.,
2011) [51]
United States

Mobile Diabetes Management Application
(MDMA) uses glucose meters and testing kits for
self-management and provides medication
support and education.
Diabetes Interactive Diary (DID) acts as a bolus
insulin calculator using self-measured blood

T2D

12

Theory(s) Used: InformationMotivation-Behavioral Skills Model
N/A

T1D

6

N/A

(Kirwan et al.,
2013) [57]
Australia
(Kleinman et al.,
2017) [61]
India

Age [Mean,
(SD)]

Gender
[n, (%)
Female]

I: 58.2 (13.6);
C: 55.8 (13.8)

I: 14
(31.11); C:
21 (58.33)

I: 57.4 (9.8);
C: 57.7 (10.0)

I: 14 (63);
C: 14 (60)

I: 58.6 (8.2);
C: 59.7 (6.8)

I: 48 (41.7);
C: 43 (37.4)

63.71

11 (39)

I: 32.9 (11.7);
C: 36.8 (14.1)

I: 37
(61.67); C:
40 (65.57)

N/A

I; 33 (23); C:
35 (18)

6

N/A

I: 52 (12); C:
53 (11)

I: 11
(35.48); C:
12 (37.5)
I: 13 (37);
C: 14 (43)

T2D

12

N/A, (*used TTM for health counseling)

I: 58.6 (11.8);
C: 55.9 (12.2)

I: 17 (33);
C: 20 (40)

T2D

3

I: 53.3; C:
53.8

N/A

I: 35.97
(10.67); C:
34.42
(10.26)
I: 48.8 (9.0);
C: 48.0 (9.5)

I: 17
(47.22); C:
27 (72.97)

N/A

I: 8 (53.3);
C: 9 (60)

I: 62.3 (6.5);
C: 61.5 (9.1)

I: 11 (46);
C: 11 (46)

I: 47.3 (6.8);
C: 47.4 (7.5)

I: 23 (62.2);
C: 11 (37.9)

I: 38.4 (10.3);
C: 34.3 (10.0)

I: 54.0C:
50.9

6

6

18

3

BC Theory

Theory Application: Assessment
Theory(s) Used: Social Cognitive
Theory; Self-Regulation Theory;
Leventhal’s Model of Illness Beliefs, and
Technology Acceptance Model (TAM)
Theory Application: Intervention design
Theory(s) Used: Social Cognitive
Theory; and Transtheoretical Model for
Health Behavior Change
Theory Application: Intervention design
Theory(s) Used: Health Belief Model;
Self-Regulation Theory;
Transtheoretical Model of Behavior
Change; Fogg Behavior Model
Theory Application: Assessment

Theory Application: Intervention design
Theory(s) Used: Situated Learning
Theory
N/A

Theory Application: Intervention design
Theory(s) Used: Health Belief Model;
Health Action Process Approach;
Theory of Planned Behavior; and
Bandura’s Theory of Self-Efficacy
Theory Application: Assessment

I: 18.2 (8);
C: 41.3 (19)

Theory(s) Used: Self Efficacy
10

Theory Application: Intervention design

(continued on next page)

5

O. El-Gayar et al.

Journal of Biomedical Informatics 119 (2021) 103839

Table 2 (continued )
Intervention Description

(Rossi et al., 2013)
[63]
Italy
(Skrøvseth et al.,
2015) [56]
Norway
(Sun et al., 2019)
[52]
China
(Waki et al., 2014)
[64]
Japan
(Wang et al.,
2019) [53]
China
(Wayne et al.,
2015) [59]
Canada
(Zhang et al.,
2019) [48]
China

Diabetes
Type
Targeted

Longest
Follow-up
(months)

BC Theory

Age [Mean,
(SD)]

Gender
[n, (%)
Female]

Diastat is a data-driven module that uses a blood
glucose meter to provide data visualization and
situation matching. Includes dietary and
physical activity components.
mHealth management application that collates
glucometer data for health recommendations
and reminders via text messaging and telephone
calls. Supports dietary and physical activity
DialBetics is designed to aid diabetes data
collection, evaluation of data, tailored feedback,
and communication with healthcare providers
mHealth application for blood glucose
monitoring and reminders, dietary support,
social support vial online forums, and feedback
from healthcare providers
Connected Wellness Platform (CWP) is an
application designed to track blood glucose,
exercise, diet. Has goal setting and progress
monitoring components

T1D

3

N/A

I: 41.07
(13.5); C:
38.33 (7.3)

I: 66.67; C:
60.00

T2D

3

N/A

I: 25
(56.82); C:
29 (61.70)

T2D

3

N/A

I: 67.9
(66–71); C:
68.04
(66–72)
I: 57.1 (10.2)
C: 57.4 (9.4)

T2D

6

N/A

I: 45.13
(7.83); C:
45.8 (8.38)

I: 27 (45);
C: 29
(48.33)

T2D

6

I: 53.1 (10.9);
C: 53.3 (11.9)

I: 31 (65);
C: 39 (80)

Welltang consists of four main components:
diabetes education, diabetes data collection
(including blood glucose physical activity, and
weight data), social support, and
communication with healthcare providers

T1D; T2D

6

I: 52 (10);
C:55 (11)

I: 28
(35.90);
C:29
(37.17)

glucose, dietary, and physical activity values.
Supports telehealth using text messages

differences (p = 0.89 and 0.34 for TTM and SCT, respectively) among
the subgroups.

N/A; (*Both control and intervention
received health coaching based on BC
theory)
N/A

I: 7/27; C:
6/27

significant. The certainty of evidence for interventions supporting five or
less BCTs was low due to inconsistency (I2 = 66%, and point estimates
that vary widely across studies), and indirectness indicating that such
interventions may reduce HbA1c slightly compared to interventions
supporting 6 or more BCTs where the certainty of the evidence was
moderate indicating that such interventions are likely to reduce HbA1c.

3.5.2. Support for behavior change techniques
A total of 17 distinct BCT were applied across the 24 intervention
groups with an average of 6.71 BCTs per intervention. The most
frequently applied BCTs to mHealth interventions were 2.3 Selfmonitoring of behavior (n = 20), 2.4 Self-monitoring of outcome(s) of
behavior (n = 20), 2.5 Feedback on outcome(s) of behavior (n = 18), 4.1
Instruction on how to perform the behavior (n = 16), and 9.1 Credible
source (n = 15). Only 2 distinct BCTs, 1.5 Review behavior goal(s) and
6.1 Demonstration of the behavior, were applied once.
Comparing the interventions that included a particular BCT with
those that did not support that particular BCT showed that for the most
part, there were no statistically significant differences between the
subgroups. The exceptions were 1.4 Action planning (p = 0.004) and 2.4
Self-monitoring of outcome (s) of Behavior (p = 0.03) where the pres
ence of these techniques showed a statistically significant reduction in
HbA1c compared to the interventions not supporting these techniques.
Taking the certainty of evidence and effect size into consideration, the
certainty of evidence for interventions supporting 1.4 Action planning
was moderate indicating that such interventions were likely to reduce
HbA1c. On the other hand, the certainty of evidence for those supporting
2.4 Self-monitoring of outcome (s) of Behavior was low as a result of the
indirectness and imprecision potentially present due to the low number
of studies in the comparison group indicating that such interventions
may reduce HbA1c.
Grouping interventions by the number of supported BCTs resulted in
significant effect sizes across all groups as shown in Table 3. Specifically,
there were 7 interventions employing 8 or more BCTs (− 0.49, 95% CI =
− 0.76 to − 0.23, p < 0.001), 10 interventions employing between 6 and
7 BCTs (− 0.36, 95% CI = − 0.51 to − 0.20, p < 0.0001), and the
remaining 7 interventions employing less than 6 BCTs (− 0.33, 95% CI
− 0.63 to 0.03, p = 0.003). While there was a decreasing trend in the
effect size as the number of BCTs increased, there were no significant
differences among the three groups (p = 0.65) and a meta-regression on
the number of BCTs (ß = − 0.02, p = 0.46) was not statistically

3.5.3. Diabetes type
Table 4 depicts the results for diabetes type and intervention dura
tion. Interventions had significant effect on glycemic control for T1D
(− 0.38, 95% CI = − 0.63 to − 0.12, p = 0.01) and for T2D (− 0.43, 95%
CI-0.58 to − 0.29, p < 0.0001). The three trials where the interventions
were designed for both T1D and T2D did not result in reductions below
the 0.30 decrease threshold (− 0.08, 95% CI = − 0.41 to 0.26, p = 0.69).
Interventions targeting T2D had the least heterogeneity. Overall, the test
for subgroup differences was not significant between the three groups (p
= 0.16) or between T1D and T2D (p = 0.69). The certainty of evidence
for T1D is low given the potential for inconsistency indicating that such
interventions may reduce HbA1c, while the certainty of evidence for
interventions targeting T2D is moderate, indicating that such in
terventions are likely to result in a reduction in HbA1c for T2D patients.
The certainty of evidence for interventions targeting both T1D and T2D
is low due to imprecision and the potential for risk of bias thereby
indicating that such interventions aimed at TD1 and T2D patients
resulted in little to no difference in the outcome.
3.5.4. Intervention duration
Groups with longer intervention duration demonstrated a statisti
cally significant improvement in glycemic control with (− 0.51, 95% CI
= − 0.72 to − 0.30, p < 0.0001) for follow-up durations greater than 9
months, and (− 0.35, 95% CI = − 0.53 to − 0.16, p < 0.001) for follow-up
greater than 3 months but less than 9 months. Shorter durations of 3
months or less had statistically insignificant reductions (− 0.28, 95% CI
= − 0.67 to 0.11, p = 0.16). However, the test for subgroup differences
did not indicate significant differences among the three time periods (p
= 0.44). Further, a meta-regression on the intervention duration was not
statistically significant (ß = − 0.03, p = 0.11).
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(a) Risk of bias graph

Fig. 3. Funnel plot of publication bias.

and the TTM were the most frequently encountered theoretical basis.
This is in contrast to Webb et al. [21], where the Theory of Planned
Behavior (TPB) was one of the most frequently used theoretical bases.
TPB was referenced once by Kleinmann et al. [61]. Three studies
[58,62,66] employed theory merely as an evaluative measure while
those that incorporated theory as part of the study design delivered only
a few details on the extent to which interventions incorporated said
theory. In Bender et al. [49], a support group was created on Facebook
based on principles drawn from SCT and TTM. Bender et al. [54]
incorporated behavioral triggers, predicated on the Health Belief Model
(HBM), the Self-Regulation Theory (SRT), the Trans Theoretical Model
(TTM), and Fogg’s Behavioral Model (FBM), for delivering text messages
as part of their application design. Hsu et al. [50] and Wayne et al. [59]
used theory mainly as part of health coaching to assist participants in
some activities and decision making. Only Orsama et al. [60] and
Kleinman et al. [61] employed various theories for application-specific
features such as reminders, feedback, and data visualization among
others to elicit behavior change.
Overall, most of the studies did not provide an explicit account of the
role of theory in the development of the mHealth intervention making it
particularly difficult to assess which is consistent with [68]. Future
research should address this issue possibly by emphasizing the need for
developing a theoretical understanding of the likely process of inducing
behavior change at the early phases of the design of an intervention [69]
and, by describing the role of theory in a ‘standardized’ form as
described in Michie and Prestwish [70]. Explicit, systematic, and rela
tively standardized description of the role of theory in the design and
development of the intervention will allow future research to not only
assess the efficacy of the role of theory in such interventions but possibly
the relation between the extent to which theory is used and the resulting
improvement in behavior and associated health outcome.

(b) Risk of bias summary

4.2. Behavior Change Techniques (BCT)

Fig. 2. Risk of bias graph and summary based on authors’ judgments.

With the evidence from the current literature pointing to an apparent
lack of details on theory, evaluating specific BCTs that promoted
behavior change was important. Consistent with Van Rhoon et al. [6]
and Webb et al. [21], BCTs associated with “goal planning”, “feedback
and monitoring”, and “providing instruction” were the most frequently
encountered. Similar to other studies [6,21], we found that the use of
BCTs in mHealth applications was generally associated with effect sizes.
Our moderator analyses identified that interventions supporting “1.4
Action planning”, “11.3 Conserving mental resources”, “2.4 Selfmonitoring of outcome(s) of behavior”, “3.2 Social support (prac
tical)”, and “9.1 Credible source” likely result in a reduction in HbA1c.
Although these BCTs resulted in the largest effect when present, only 1.4
Action planning and 2.4 Self-monitoring of outcome(s) of behavior were
statistically different from those that did not apply them. The results are

4. Discussion
This meta-analysis examined the efficacy of mHealth based in
terventions for health behavior change in diabetes patients by evalu
ating their effect on glycemic control. The evidence demonstrated that
the use of mHealth app-supported interventions likely result in im
provements in HbA1c levels of participants as compared to standard
care. An in-depth discussion of specific intervention characteristics and
their effect on glycemic control is presented in the ensuing discussion.
4.1. Behavior change theory
Consistent with Van Rhoon et al. [6] and Webb et al. [21], the SCT
7
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Fig. 4. Forest plot of mHealth interventions vs standard care for glycemic control.

4.3. Diabetes type

generally consistent with Liu et al. [8] where the focus was on features
(as opposed to behavior change techniques) related to monitoring,
feedback, goal-setting, and patient-provider communication. In this re
view, a likely reduction in HbA1c was observed in interventions sup
porting these features. However, results were mixed when comparing
between groups supporting such features versus those that did not.
Further, we interpret this result to mean that the features involving
reduced demands on mental resources of patients (conserving mental
resources) such as automatic bolus insulin recommendation advice re
ported in some studies [46,50,65] instigated a reduction in the risk of
diabetes burnout. Similarly, because diabetes management depends on
the timing and amount of diet, exercise, and medication, detailed
planning of specific behaviors and goals to be achieved (action planning
and self-monitoring of outcomes of behaviors, respectively) contributed
to an increase in the effectiveness of the interventions. As reported in a
recent study [71], pairing such techniques with prompts and cues, and
tailored feedback, assist in reinforcing the value of medication adher
ence in diabetes patients and contribute to the overall wellbeing of pa
tients. For example, Kleinman et al. [61] included a blood glucose
testing schedule which the authors posit as a possible intermediary to
the improved HbA1c levels of intervention participants. A similar
feature was available in an app designed by Kusnanto et al. [62] which
also resulted in a likely reduction in HbA1c. However, it must be noted
that Drion et al’s [55] app which allowed patients to personalize ac
tivities consistent with their schedule did not result in significant dif
ferences between intervention and control groups after 3 months.
It is worth noting that interventions that included significant pro
vider involvement, coded as “9.1 Credible source” are likely associated
with a moderate increase in the effectiveness of the interventions.
However, the results are not statistically different from those that did
not include such support. In essence, it appears that on average, mHealth
interventions with clinical support might be associated with relatively
larger improvements, but the evidence is inconclusive. Further research
is warranted to assess the benefit provided by access to a credible source
such as healthcare providers.

Subgroup analysis based on the types of diabetes targeted and the
duration of the intervention showed that they influenced clinical out
comes. For the type of diabetes, the results are consistent with Wu et al.
[11] where both T1D and T2D groups likely resulted in a negative effect
size reflecting a reduction in HbA1c with no significant differences be
tween the two groups. It is also consistent with Kitsiou et al. [72] where
on average, mHealth interventions improve glycemic control (HbA1c)
compared to standard care.
However, interventions targeting T2D had a sizable reduction in
heterogeneity in contrast to the entire sample. Studies targeting T1D or a
combination of T1D and T2D delivered mixed results. Some of these
studies [48,56] reporting an opposite effect on the outcome appear to
have contributed to the relatively higher heterogeneity of the sample.
One possible explanation is that T1D is much harder to control as
compared to T2D which can often be managed with lifestyle modifica
tions alone [73,74]. Regardless, this result should be interpreted with
caution since the difference between the three groups did not reach
statistical significance and the number of studies in the T1D group and
the T1D & T2D groups was relatively small.
4.4. Intervention duration
We also observed a likely reduction in HbA1c in both long- and
medium-term study durations (greater than 9 months and 3 to 9 months
respectively). These interventions achieved the 0.3% HbA1c reduction
threshold set to signal effectiveness as defined in this study. Shorterterm studies had small but statistically insignificant effect sizes. The
finding that intervention effectiveness likely increases with trial dura
tion are comparable to the results reported in a recent systematic review
on T1D involving eight mobile applications and text message-based in
terventions [12]. However, we found that there were no significant
differences between the three groups of short-, medium- or long-term
follow-up durations. This non-significant difference was confirmed in
8
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Table 3
Moderator analysis based on behavior change theory and techniques.
#
Interv.
Presence of Behavior
Theory
Yes

8

No

16

Theoretical Basis
Transtheoretical Model
of Health Behavior
Change (TTM)
Social Cognitive Theory
(SCT) and Self-Efficacy
Health Belief Model
(HBM)
Self-Regulation Theory
(SRT)
Fogg Behavior Model
(FBM)
Situated Learning Theory
(SLT)
Theory of Planned
Behavior (TPB)
Information-MotivationBehavioral Skills Model
(IMBS)
Health coaching
Number of BCTs Supported
<=5

>=6 & <=7

>=8

Behavior Change
Techniques
1 Goals and planning

3
4
2

Q

p

− 0.36
[− 0.60;
− 0.13]
− 0.39
[− 0.54;
− 0.24]

6.62

0%

0.002

22.58

34%

<0.0001

− 0.35
[− 0.88;
0.18]
− 0.23
[− 0.56,
0.10]

4.50

56%

0.2

4.1 Instruction on how to
perform the behavior

16

0.70

0%

0.18

5.1 Information about
health consequences

10

7.1 Prompts/cues

9

9.1 Credible source

15

11.3 Conserving mental
resources

5

1
1

3.1 Social support
(unspecified)

3

3.2 Social support
(practical)

4

1
1

7
10
7

19

1.2 Problem solving

4

1.3 Goal setting
(outcome)

12

1.4 Action planning

10
22

2.2 Feedback on
behavior

9

2.3 Self-monitoring of
behavior

20

2.4 Self-monitoring of
outcome(s) of behavior

20

2.7 Feedback on outcome
(s) of behavior

18
7

Effect
Estimate
(95% CI)
− 0.38
[− 0.61;
− 0.14]
− 0.34
[− 0.79;
0.11]
− 0.40
[− 0.71;
− 0.10]
− 0.38
[− 0.53;
− 0.23]
− 0.26
[− 0.46;
− 0.06]
− 0.39
[− 0.58;
− 0.20]
− 0.41
[− 0.55;
− 0.28]
− 0.59
[− 0.87;
− 0.30]

Q

I2

p

2.52

21

1.14

3.57

16%

0.01

15.4

3%

<0.0001

11.03

18%

0.01

11.83

32%

<0.0001

12.83

0%

<0.0001

9.53

58%

<0.0001

Table 4
Subgroup analysis for diabetes type and intervention duration.

1

5

3 Social support

#
Interv.

Effect
Estimate
(95% CI)

2

1.1 Goal setting
(behavior)

2 Feedback and monitoring

I2

Table 3 (continued )

− 0.33
[− 0.63;
− 0.03]
− 0.36
[− 0.51;
− 0.20]
− 0.49
[− 0.76;
− 0.23]

17.62

66%

0.003

2.85

0%

<0.0001

− 0.37
[− 0.53;
− 0.22]
− 0.32
[− 0.60;
− 0.03]
− 0.33
[− 0.69;
0.02]
− 0.33
[− 0.54;
− 0.12]
− 0.61
[− 0.81;
− 0.41]
− 0.39
[− 0.53;
− 0.26]
− 0.32
[− 0.48;
− 0.17]
− 0.39
[− 0.52;
− 0.26]
− 0.43
[− 0.56;
− 0.31]
− 0.39
[− 0.54;
− 0.24]

25.83

7.51

20%

30%

Diabetes Type
T1D

<0.001

14%

0.03

4.32

31%

0.07

14.53

24%

0.003

10.31

13%

<0.0001

28.39

26%

<0.0001

5.06

0%

<0.0001

26.5

28%

<0.0001

21.91

13%

<0.0001

18.88

10%

<0.0001

6.21

3%

<0.001

Effect Estimate
(95% CI)

Q

I2

p

6

− 0.38 [− 0.63;
− 0.12]
− 0.43 [− 0.58;
− 0.29]
− 0.08 [− 0.41;
0.26]

7.54

34%

0.01

15.38

9%

<0.0001

2.37

16%

0.66

− 0.28 [− 0.67;
0.11]
− 0.35 [− 0.53;
− 0.16]
− 0.51 [− 0.72;
− 0.30]

3.77

0%

0.16

19.08

42%

<0.001

4.13

0%

<0.0001

T2D

15

T1D&T2D

3

Trial Duration
(months)
<=3

5

>3 & <=9

12

>9

7

<0.0001

4.66

#
Interventions

a meta-regression analysis of the trial duration on intervention effec
tiveness. This finding suggests the need for further investigation into
whether intervention effectiveness increases with sustained use.
4.5. Limitations of the study
One of the main strengths of this study lies in the use of replicable
BCTs [14] to code intervention-specific features that foster behavior
change. While BCT coding assisted in identifying the specific “active
ingredients” in mHealth app-based interventions, their interpretation and
coding were dependent on the details provided in the literature
reporting said interventions. This is a shortcoming that has been re
ported in reviews of this nature [6,23,24]. Another limitation relates to
the reliance on what is reported in the manuscripts concerning the
techniques used or the theory cited. This has also been encountered in
prior reviews [21]. Accordingly, in this study, we opted to investigate
the presence versus absence of theory as opposed to attempting to infer
the precise role of theory in driving the design of the intervention.
Further, while there is a reasonable number of interventions included in
the meta-analysis to evaluate the overall effect size as well as to conduct
moderator analyses, the number of studies is not enough to evaluate
9
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multiple moderators simultaneously to better assess possible interaction
effects. Moreover, as BCTs provide a synthetic aggregation of imple
mentation constructs that may be core to multiple behavior change
theories, including the ones reported, theory use and BCT use can be
seen as two inherently dependent tasks for the studies that mention
theory use. A subcomponent analysis of BCT prevalence in studies
driven by theory may offer interesting insights as more studies become
available. On another note, the review relies on PubMed/Medline and
Web of Science. While we carefully examined citations of prior related
reviews [4–12] in order to not inadvertently rule out any potentially
useful study, there is a possibility that eligible studies in other databases
such as CENTRAL and EMBASE may have been missed. Last but not
least, it is also worth noting that the current review focused on HbA1c as
an outcome. However, minimizing glycemic variability has been advo
cated for the prevention of cardiovascular events [75]. The ubiquity and
pervasiveness of mobile apps coupled with behavioral change may offer
opportunities for reducing glycemic variability. Future research may
emphasize interventions aimed at reducing such variability.
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5. Conclusion
The potential for mHealth applications to foster health behavior
change for diabetes self-management and regimen adherence is inves
tigated in this meta-analysis. This study evaluates the efficacy of
mHealth interventions compared to standard care for achieving glyce
mic control in diabetes patients with a particular focus on the role of
theory and behavioral change techniques. Consistent with the results of
prior studies, we found evidence from 21 studies that the use of mHealth
app-supported interventions is likely to result in improvements in
HbA1c levels of participants as compared to standard care. The results
show that the use of BCTs is generally associated with likely higher
HbA1c reductions. BCT 1.4 Action planning and BCT 2.4 Selfmonitoring of (outcome of) behavior were the only two techniques
that demonstrated statistically significant differences in effect sizes be
tween interventions that supported these techniques compared to those
that did not. Further, the use of behavior theory did not differ signifi
cantly from those not using theory for intervention design.
Overall, this study is the first meta-analysis specifically investigating
the effect size and quality of evidence of mobile-based interventions for
diabetes self-management with a particular focus on exploring the role
of behavioral change techniques and theory. The study has several
theoretical and practical implications. Most notably, despite the
importance of theory-based interventions [6,21,76] and given that the
use of theory was often unclear in how it influenced intervention com
ponents, this study highlights the importance of linking theoretical
constructs to intervention components to increase their effectiveness.
There is also a need for an explicit account of how theory is used as a
basis for any proposed intervention. One possibility is to rely on some
conceptualization of theory use such as the one proposed by Michie and
Prestwish [70]. Further, while some interventions mention behavioral
change as a focus, the nature of the targeted behavior change is not often
obvious. Clearly articulating the targeted behavioral change that is used
as a mediator for the intended health outcome can provide sufficient
details for further exploring 1) the role of behavioral change as a
mediator, and 2) understand which theoretical basis and BCTs are
effective in inducing the needed behavioral change and associated
health outcome.
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[72] S. Kitsiou, G. Paré, M. Jaana, B. Gerber, Effectiveness of mHealth interventions for
patients with diabetes: An overview of systematic reviews, PLoS ONE 12 (2017),
e0173160, https://doi.org/10.1371/journal.pone.0173160.
[73] American Diabetes Association, Diagnosis and Classification of Diabetes Mellitus,
Diabetes Care 37 (2014) S81–S90. https://doi.org/10.2337/dc14-S081.
[74] J.T. Markowitz, T. Cousineau, D.L. Franko, A.T. Schultz, M. Trant, R. Rodgers, L.M.
B. Laffel, Text messaging intervention for teens and young adults with diabetes,
J. Diabet. Sci. Technol. 8 (2014) 1029–1034, https://doi.org/10.1177/
1932296814540130.
[75] S. Suh, J.H. Kim, Glycemic Variability: How Do We Measure It and Why Is It
Important? Diabet. Metab. J. 39 (2015) 273–282, https://doi.org/10.4093/
dmj.2015.39.4.273.
[76] O. El-Gayar, P. Timsina, N. Nawar, W. Eid, Mobile Applications for Diabetes SelfManagement: Status and Potential, J. Diabet. Sci. Technol. 7 (2013) 247–262,
https://doi.org/10.1177/193229681300700130.

12

